Related Experiment Video
Updated: Jul 10, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Regulatory T cells: potential target in anticancer immunotherapy.
Chi-Mou Juang1, Chien-Fu Hung, Jiun-Yih Yeh
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Veterans General Hospital, Taipei, Taiwan.
Taiwanese Journal of Obstetrics & Gynecology
|October 27, 2007
Summary
Regulatory T cells, initially termed suppressive T cells, are crucial in cancer immunity. Understanding their role in tumor growth and immune evasion is key for advancing cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Regulatory T cells (Tregs) were initially described as suppressive T cells in the 1970s.
- Early research faced skepticism, but the identification of CD25 as a marker in 1995 revitalized Treg studies.
- Tregs play significant roles in cancer, autoimmune diseases, transplantation, and pregnancy.
Purpose of the Study:
- To discuss the mechanisms of regulatory T cell-mediated immunosuppression in cancer.
- To explore the potential clinical applications of targeting regulatory T cells in cancer immunotherapy.
Main Methods:
- Review of historical and recent scientific literature on regulatory T cells.
- Analysis of the role of regulatory T cells in tumor immune evasion.
- Discussion of clinical strategies involving regulatory T cells for cancer treatment.
Main Results:
- Regulatory T cells are implicated in tumor immune evasion and hinder effective cancer immunotherapy.
- Targeting regulatory T cells presents a promising strategy for enhancing anti-cancer immunity.
Conclusions:
- Regulatory T cells are critical players in cancer pathogenesis and immune evasion.
- Modulating regulatory T cell activity holds significant potential for improving cancer immunotherapy outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...